top of page

John Doorley Featured in Financial Times

AstraZeneca Communications Headache

“When something goes wrong with a product, it’s seldom the case that it’s only a communications problem, but that appears to be the case with the AstraZeneca vaccine,” said John Doorley, associate professor of strategic communications at Elon University and former corporate communications director at Merck.

“The available data show they’ve got a great vaccine and they're offering it in a way that’s civically responsible, but it looks like the rush to satisfy legitimate communication pressures from the stock market and public health officials has led to some missteps.”

(download full article)

Financial Times AstraZeneca 25March2021
Download • 353KB


bottom of page